Preparation and optimization of media using Pluronic® micelles for solubilization of sirolimus and release from the drug eluting stents

Colloids and Surfaces B: Biointerfaces

Volumn 93, Issue , 2012, Pages 180-187

  Raval, Ami ^b   Parmar, Arpan ^a   Raval, Ankur ^b   Bahadur, Pratap ^a  

^a VEER NARMAD SOUTH GUJARAT UNIVERSITY   (India)

^b Research and Development Department   (India)

Author keywords

Drug eluting stent (DES); In vitro release; Micelle; Pluronic ; Sirolimus (SRL); Solubilization

Indexed keywords

DRUG-ELUTING STENTS; IN-VITRO; PLURONICS; SIROLIMUS; SOLUBILIZATION;

BLOCK COPOLYMERS; DRUG PRODUCTS; DYNAMIC LIGHT SCATTERING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICELLES; OPTIMIZATION; SOLUBILITY; THERMODYNAMICS; ULTRAVIOLET VISIBLE SPECTROSCOPY;

STENTS;

POLOXAMER; RAPAMYCIN;

ARTICLE; CONTROLLED STUDY; DRUG ANALYSIS; DRUG ELUTING STENT; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; HYDRODYNAMICS; HYDROPHILICITY; MICELLE; MICELLIZATION; PARTICLE SIZE; PH; PRIORITY JOURNAL; PROCESS OPTIMIZATION; TEMPERATURE; ULTRAVIOLET SPECTROSCOPY;

CHROMATOGRAPHY, REVERSE-PHASE; DRUG STABILITY; DRUG-ELUTING STENTS; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KINETICS; MICELLES; PARTICLE SIZE; POLOXAMER; SIROLIMUS; SOLUBILITY; SPECTRUM ANALYSIS; TEMPERATURE; THERMODYNAMICS; WATER;

EID: 84857788067     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.12.034     Document Type: Article

References (47)

1. Morice M.C., Serruys P.W., Sousa J.E. N. Engl. J. Med. 2002, 346:1773-1780.
2. Moses J.W., Leon M.B., Popma J.J. N. Engl. J. Med. 2003, 349:1315-1323.
3. Naseerali C.P., Hari P.R., Sreenivasan K. J. Chromatogr. B 2010, 878:709-712.
4. Neu H., Young L., Zinner S. The New Macrolides, Azalides and Streptogramins-Pharmacology and Clinical Applications 1992, Dekker, New York.
5. O'Sullivan N., Wise R. Curr. Opin. Infect. Dis. 1990, 3:743-750.
6. Cunha B. Adv. Ther. 1996, 13:29-37.
7. VanDuyne G., Standaert R., Karplus P., Schreiber S., Clardy J. Science 1991, 252:839-842.
8. Baumann K., Hogenauer K., Schulz G., Steck A. Mag. Res. Chem. 2002, 40:443-448.
9. P.R. Waranis, W.T. Leonard, Rapamycin formulation for IV injection, US Patent No. 5,616,558 (1997).
10. Simamora P., Alvarez J.M., Yalkowsky S.H. Int. J. Pharm. 2001, 213:25-29.
11. Tanaka H., Kuroda A., Marusawa H., Hatanaka H., Kino T., Goto T., Hashimoto M., Taga T. J. Am. Chem. Soc. 1987, 109:5031.
12. Groth C.G., Backman L., Morales J.M., Calne R., Kreis H., Lang P., Touraine J.L., Claesson K., Campistol J.M., Durand D., Wramner L., Brattstrom C., Charpentier B. Transplantation 1999, 67:1036.
13. Jariwala A., Engineer C., Kotadia H., Raval A., Kothwala D. Trends Biomater. Artif. Org. 2008, 22:83.
14. Zackrisson G., Ostling G., Skanderberg B., Anfält T. J. Pharm. Biomed. Anal. 1995, 13:377-383.
15. Miyako Y., Tai H., Ikeda K., Kume R., Pinal R. Drug Dev. Ind. Pharm. 2008, 34:499.
16. Sanghvi R., Narazaki R., Machatha S.G., Yalkowsky S.H. AAPS PharmSciTech 2008, 9:366.
17. Uch A.S., Hesse U., Dressman J.B. Pharm. Res. 1999, 16:968.
18. Jain P., Yalkowsky S.H. Int. J. Pharm. 2007, 342:1.
19. Hodgdon T.K., Kaler E.W. Curr. Opin. Colloid Interface 2007, 12:121.
20. Riess G., Hurtrez G., Bahadur P. Block Copolymers, Encyclopedia of Polymer Science and Engineering 1985, Wiley, New York. 2nd ed.
21. Bahadur P. Curr. Sci. 2001, 80:1002.
22. Riess G. Prog. Polym. Sci. 2003, 28:1107.
23. Kabanov A.V., Batrakova E.V., Alakhov V.Y. J. Control. Release 2002, 82:189.
24. Gaucher G., Dufresne M.H., Sant V.P., Kang N., Maysinger D., Leroux J.C. J. Control. Release 2005, 109:169.
25. Ilichev Y.V., Alquier L., Maryanoff C.A. xii. ARKIVOC 2007, 110-131.
26. Faisant N., Akiki J., Siepmann F., Benoit J.P., Siepmann J. Int. J. Pharm. 2006, 314:189-197.
27. Sezgin Z., ksel N.Y., Baykara T. Eur. J. Pharm. Biopharm. 2006, 64:261-268.
28. Torchilin V.P. J. Control. Release 2001, 73:137-172.
29. Savic R., Eisenberg A., Maysinger D. J. Drug Target. 2006, 14:343.
30. Mahmud A., Xiong X.B., Aliabadi H.M., Lavasanifar A. J. Drug Target. 2007, 15:553.
31. Batrakova E.V., Kabanov A.V. J. Control. Release 2008, 130:98.
32. Yokoyama M., Satoh A., Sakurai Y., Okano T., Matsumura Y., Kakizoe T., Kataoka K. J. Control. Release 1998, 55(2-3):219-229.
33. Yu B.G., Okano T., Kataoka K., Kwon G. J. Control. Release 1998, 53(1-3):131-136.
34. Bahadur P., Riess G. Tenside Surfact. Det. 1991, 28:173.
35. Paine M.F., Leung L.Y., Lim H.K., Liao K., Oganesian A., Zhang M.Y., Thummel K.E., Watkins P.B. Am. Soc. Pharmacol. Exp. Ther. 2002, 301(1):174-186.
36. Gaisford S., Beezer A.E., Mitchell J.C. Langmuir 1997, 13:2606.
37. Gaisford S., Beezer A.E., Mitchell J.C., Loh W., Finnie J.K., Williams S.J. J. Chem. Soc. Chem. Commun. 1995, 18:1843.
38. Moore J.W., Flanner H.H. Pharm. Tech. 1996, 20:64-74.
39. Wang X., Venkatraman S.S., Boey F.Y.C., Loo J.S.C., Tan L.P. Biomaterials 2006, 27:5588.
40. J.L. Toner, S.E. Burke, K.R. Cromack, Zotarolimus-containing delivery system for implantation into a body lumen of subject, US Patent No. WO/2007/111925 (2007).
41. Yang S., Zhang X., Yuan S. J. Mol. Model. 2008, 14:607.
42. Kadam Y., Yerramilli U., Bahadur A. Colloids Surf. B: Biointerfaces 2009, 72:141-147.
43. Rosen M.J. Surfactant and Interfacial Phenomena 2004, Wiley-Interscience/John Wiley & Sons, Inc., Hoboken, NJ, United States of America. third ed.
44. Bhat P.A., Rather G.M., Dar A.A. J. Phys. Chem. B 2009, 113:997-1006.
45. Enache M., Anghelache I., Volanschi E. Int. J. Pharm. 2010, 390:100-106.
46. Cudina O., Rajic K.K., Bugarcic I.R., Jankovic I. Colloids Surf. A: Physicochem. Eng. Aspects 2005, 256:225-232.
47. FDA Draft Guidance for Industry: Coronary Drug-Eluting Stents-Nonclinical and Clinical Studies. FDA, March 2008.